
BMCCANCER . BIOMEDCENTRAL . COM {
}
Title:
Androgen receptor expresion in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors | BMC Cancer | Full Text
Description:
Background In the present study we analyze, in patients with breast cancer, the tumor expression of androgen receptors (AR), its relationship with clinicopathological characteristics and with the expression of several matrix metalloproteases (MMPs) and their inhibitors (TIMPs), as well as with prognosis. Methods An immunohistochemical study was performed using tissue microarrays and specific antibodies against AR, MMPs -1, -2, -7, -9, -11, -13, -14, and TIMPs -1, -2 and -3. More than 2,800 determinations on tumor specimens from 111 patients with primary invasive ductal carcinoma of the breast (52 with axillary lymph node metastases and 59 without them) and controls were performed. Staining results were categorized using a score based on the intensity of the staining and a specific software program calculated the percentage of immunostained cells automatically. Results A total of 83 cases (74.8%) showed a positive immunostaining for AR, but with a wide variation in the staining score values. There were no significant associations between the total immunostaining scores for AR and any clinicopathological parameters. However, score values for MMP-1, -7 and -13, were significantly higher in AR-positive tumors than in AR-negative tumors. Likewise, when we considered the cellular type expressing each factor, we found that AR-positive tumors had a higher percentage of cases positive for MMP-1, -7, -11, and TIMP-2 in their malignant cells, as well as for MMP-1 in intratumoral fibroblasts. On the other hand, multivariate analysis demonstrated that patients with AR-positive tumors have a significant longer overall survival than those with AR-negative breast carcinomas (p = 0.03). Conclusion Our results confirm that AR are commonly expressed in breast cancer, and are correlated with the expression of some MMPs and TIMP-2. Although we found a specific value of AR expression to be a prognostic indicator in breast cancer, the functional role of AR in these neoplasms is still unclear and further data are needed in order to clarify their biological signification in breast cancer.
Website Age:
25 years and 10 months (reg. 1999-08-06).
Matching Content Categories {馃摎}
- Education
- Social Networks
- Health & Fitness
Content Management System {馃摑}
What CMS is bmccancer.biomedcentral.com built with?
Custom-built
No common CMS systems were detected on Bmccancer.biomedcentral.com, and no known web development framework was identified.
Traffic Estimate {馃搱}
What is the average monthly size of bmccancer.biomedcentral.com audience?
馃殌 Good Traffic: 50k - 100k visitors per month
Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Bmccancer.biomedcentral.com Make Money? {馃捀}
Display Ads {馃幆}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (3)
yourbow.com, google.com, doceree.comHow Much Does Bmccancer.biomedcentral.com Make? {馃挵}
Display Ads {馃幆}
$690 per month
Our analysis indicates Bmccancer.biomedcentral.com generates between $462 and $1,271 monthly online from display ads.
Keywords {馃攳}
bmc, cookies, privacy, mmp, page, data, cancer, optional, content, personal, parties, policy, information, manage, submission, positive, article, contact, enquiries, editing, authors, choice, essential, make, site, function, advertising, personalisation, usage, analysis, social, media, accepting, consent, processing, including, transfers, european, economic, area, varying, standards, protection, preferences, change, choices, accept, skip, main, advertisement,
Topics {鉁掞笍}
authors scientific editing privacy choices/manage cookies bmc european economic area androgen receptor expresion malignant cells positive state privacy rights accepting optional cookies 1471-2407 contact manage preferences personal data breast cancer submission enquiries optional cookies data protection essential cookies cookies skip fibroblasts positive cookies policy privacy policy privacy statement usage analysis social media varying standards clinicopathological characteristics general enquiries preference centre springer nature content choices privacy choice make site function advertising personalisation consent processing parties information change accept published relationship tumors prognosis expression metalloproteases ar
Schema {馃椇锔弣
WebPage:
mainEntity:
headline:Androgen receptor expresion in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors
description:In the present study we analyze, in patients with breast cancer, the tumor expression of androgen receptors (AR), its relationship with clinicopathological characteristics and with the expression of several matrix metalloproteases (MMPs) and their inhibitors (TIMPs), as well as with prognosis. An immunohistochemical study was performed using tissue microarrays and specific antibodies against AR, MMPs -1, -2, -7, -9, -11, -13, -14, and TIMPs -1, -2 and -3. More than 2,800 determinations on tumor specimens from 111 patients with primary invasive ductal carcinoma of the breast (52 with axillary lymph node metastases and 59 without them) and controls were performed. Staining results were categorized using a score based on the intensity of the staining and a specific software program calculated the percentage of immunostained cells automatically. A total of 83 cases (74.8%) showed a positive immunostaining for AR, but with a wide variation in the staining score values. There were no significant associations between the total immunostaining scores for AR and any clinicopathological parameters. However, score values for MMP-1, -7 and -13, were significantly higher in AR-positive tumors than in AR-negative tumors. Likewise, when we considered the cellular type expressing each factor, we found that AR-positive tumors had a higher percentage of cases positive for MMP-1, -7, -11, and TIMP-2 in their malignant cells, as well as for MMP-1 in intratumoral fibroblasts. On the other hand, multivariate analysis demonstrated that patients with AR-positive tumors have a significant longer overall survival than those with AR-negative breast carcinomas (p = 0.03). Our results confirm that AR are commonly expressed in breast cancer, and are correlated with the expression of some MMPs and TIMP-2. Although we found a specific value of AR expression to be a prognostic indicator in breast cancer, the functional role of AR in these neoplasms is still unclear and further data are needed in order to clarify their biological signification in breast cancer.
datePublished:2008-05-28T00:00:00Z
dateModified:2008-05-28T00:00:00Z
pageStart:1
pageEnd:10
license:https://creativecommons.org/licenses/by/2.0
sameAs:https://doi.org/10.1186/1471-2407-8-149
keywords:
Immunostaining Score
Tissue Array Block
Total Immunostaining Score
Primary Invasive Ductal Carcinoma
Apocrine Breast Carcinoma
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-8-149/MediaObjects/12885_2007_Article_1087_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-8-149/MediaObjects/12885_2007_Article_1087_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-8-149/MediaObjects/12885_2007_Article_1087_Fig3_HTML.jpg
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:8
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Luis O Gonzalez
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Anatom铆a Patol贸gica, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Maria D Corte
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Julio Vazquez
affiliation:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital 脕lvarez Buylla
address:
name:Servicio de Ginecolog铆a, Hospital 脕lvarez Buylla, Mieres, Spain
type:PostalAddress
type:Organization
type:Person
name:Sara Junquera
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Rosario Sanchez
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Ana C Alvarez
type:Person
name:Juan C Rodriguez
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Cirug铆a General, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Maria L Lamelas
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Ginecolog铆a, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Francisco J Vizoso
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Cirug铆a General, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Androgen receptor expresion in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors
description:In the present study we analyze, in patients with breast cancer, the tumor expression of androgen receptors (AR), its relationship with clinicopathological characteristics and with the expression of several matrix metalloproteases (MMPs) and their inhibitors (TIMPs), as well as with prognosis. An immunohistochemical study was performed using tissue microarrays and specific antibodies against AR, MMPs -1, -2, -7, -9, -11, -13, -14, and TIMPs -1, -2 and -3. More than 2,800 determinations on tumor specimens from 111 patients with primary invasive ductal carcinoma of the breast (52 with axillary lymph node metastases and 59 without them) and controls were performed. Staining results were categorized using a score based on the intensity of the staining and a specific software program calculated the percentage of immunostained cells automatically. A total of 83 cases (74.8%) showed a positive immunostaining for AR, but with a wide variation in the staining score values. There were no significant associations between the total immunostaining scores for AR and any clinicopathological parameters. However, score values for MMP-1, -7 and -13, were significantly higher in AR-positive tumors than in AR-negative tumors. Likewise, when we considered the cellular type expressing each factor, we found that AR-positive tumors had a higher percentage of cases positive for MMP-1, -7, -11, and TIMP-2 in their malignant cells, as well as for MMP-1 in intratumoral fibroblasts. On the other hand, multivariate analysis demonstrated that patients with AR-positive tumors have a significant longer overall survival than those with AR-negative breast carcinomas (p = 0.03). Our results confirm that AR are commonly expressed in breast cancer, and are correlated with the expression of some MMPs and TIMP-2. Although we found a specific value of AR expression to be a prognostic indicator in breast cancer, the functional role of AR in these neoplasms is still unclear and further data are needed in order to clarify their biological signification in breast cancer.
datePublished:2008-05-28T00:00:00Z
dateModified:2008-05-28T00:00:00Z
pageStart:1
pageEnd:10
license:https://creativecommons.org/licenses/by/2.0
sameAs:https://doi.org/10.1186/1471-2407-8-149
keywords:
Immunostaining Score
Tissue Array Block
Total Immunostaining Score
Primary Invasive Ductal Carcinoma
Apocrine Breast Carcinoma
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-8-149/MediaObjects/12885_2007_Article_1087_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-8-149/MediaObjects/12885_2007_Article_1087_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-8-149/MediaObjects/12885_2007_Article_1087_Fig3_HTML.jpg
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:8
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Luis O Gonzalez
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Anatom铆a Patol贸gica, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Maria D Corte
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Julio Vazquez
affiliation:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital 脕lvarez Buylla
address:
name:Servicio de Ginecolog铆a, Hospital 脕lvarez Buylla, Mieres, Spain
type:PostalAddress
type:Organization
type:Person
name:Sara Junquera
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Rosario Sanchez
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Ana C Alvarez
type:Person
name:Juan C Rodriguez
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Cirug铆a General, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Maria L Lamelas
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Ginecolog铆a, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
type:Person
name:Francisco J Vizoso
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Cirug铆a General, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:BMC Cancer
issn:
1471-2407
volumeNumber:8
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
name:Hospital de Jove
address:
name:Servicio de Anatom铆a Patol贸gica, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
name:Hospital 脕lvarez Buylla
address:
name:Servicio de Ginecolog铆a, Hospital 脕lvarez Buylla, Mieres, Spain
type:PostalAddress
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
name:Hospital de Jove
address:
name:Servicio de Cirug铆a General, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
name:Hospital de Jove
address:
name:Servicio de Ginecolog铆a, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
name:Hospital de Jove
address:
name:Servicio de Cirug铆a General, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Luis O Gonzalez
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Anatom铆a Patol贸gica, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Maria D Corte
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Julio Vazquez
affiliation:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital 脕lvarez Buylla
address:
name:Servicio de Ginecolog铆a, Hospital 脕lvarez Buylla, Mieres, Spain
type:PostalAddress
type:Organization
name:Sara Junquera
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Rosario Sanchez
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Ana C Alvarez
name:Juan C Rodriguez
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Cirug铆a General, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Maria L Lamelas
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Ginecolog铆a, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Francisco J Vizoso
affiliation:
name:Unidad de Investigaci贸n, Hospital de Jove
address:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
name:Instituto Universitario de Oncolog铆a del Principado de Asturias
address:
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
type:PostalAddress
type:Organization
name:Hospital de Jove
address:
name:Servicio de Cirug铆a General, Hospital de Jove, Gij贸n, Spain
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
name:Servicio de Anatom铆a Patol贸gica, Hospital de Jove, Gij贸n, Spain
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
name:Servicio de Ginecolog铆a, Hospital 脕lvarez Buylla, Mieres, Spain
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
name:Servicio de Cirug铆a General, Hospital de Jove, Gij贸n, Spain
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
name:Servicio de Ginecolog铆a, Hospital de Jove, Gij贸n, Spain
name:Unidad de Investigaci贸n, Hospital de Jove, Gij贸n, Spain
name:Instituto Universitario de Oncolog铆a del Principado de Asturias, Oviedo, Spain
name:Servicio de Cirug铆a General, Hospital de Jove, Gij贸n, Spain
External Links {馃敆}(21)
- Profit of https://www.biomedcentral.com/privacy-statement
- What's the financial intake of https://www.biomedcentral.com?
- How profitable is https://www.biomedcentral.com/journals?
- What's the income generated by https://www.biomedcentral.com/getpublished each month?
- How much does https://www.biomedcentral.com/about rake in every month?
- Get to know what's the income of https://www.biomedcentral.com/account
- Get to know what's the income of https://submission.nature.com/new-submission/12885/3
- Earnings of https://blogs.biomedcentral.com/
- What are the total earnings of https://www.biomedcentral.com/login?
- How much income does https://authorservices.springernature.com/go/sn/?utm_source=Website&utm_medium=BMC&utm_campaign=SNAS+Referrals+2022&utm_id=ref2022 have?
- Learn how profitable https://www.biomedcentral.com/about/policies is on a monthly basis
- What's the monthly income of https://www.biomedcentral.com/accessibility?
- What is the monthly revenue of https://www.biomedcentral.com/about/press-centre?
- How much does https://support.biomedcentral.com/support/home rake in every month?
- What's the income of https://biomedcentral.typeform.com/to/VLXboo?
- How much does https://www.biomedcentral.com/about/jobs make?
- See how much http://www.weibo.com/biomedcentral makes per month
- What's the revenue for https://www.biomedcentral.com/terms-and-conditions?
- What is the earnings of https://www.springernature.com/ccpa?
- https://www.biomedcentral.com/cookies's financial summary
- How much revenue does https://www.springernature.com bring in?
Analytics and Tracking {馃搳}
- Google Tag Manager
Libraries {馃摎}
- Prism.js
CDN Services {馃摝}
- Crossref